BIOSERGEN AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.33 SEK | -.--% |
|
-4.07% | -62.50% |
| 09/04 | Biosergen to Issue New Units as Compensation Under Rights Issue | MT |
| 27/03 | Biosergen Raises SEK26.4 Million via Rights Issue | MT |
Chart calendar Biosergen AB
a14a9a7099173220eeba8f1d80fe2e.fbOgyahtdtlH6aOW3MyMjMmbqxJdamfijx6z0A8Bojk.OuXzocdAELtxqs3gkL__6L7qnj9rGVPU_FX1sjZA9gsV55WI4i8v4TaB8g~08ea1e42b78ac35780e28af6310ad2a4
Upcoming events on Biosergen AB
Past events on Biosergen AB
| 29/03/2024 | Q4 2023 Earnings Release |
| 06/12/2023 | Carlsquare Nordic Life Science Investor Day |
| 30/11/2023 | Q3 2023 Earnings Release |
| 31/08/2023 | Q2 2023 Earnings Release |
| 31/05/2023 | Annual General Meeting |
| 31/05/2023 | Q1 2023 Earnings Release |
| 31/03/2023 | Q4 2022 Earnings Release |
| 30/11/2022 | Q3 2022 Earnings Release |
| 31/08/2022 12:19 pm | Interim 2022 Earnings Release |
| 31/05/2022 12:30 pm | Q1 2022 Earnings Release |
| 28/04/2022 | Annual General Meeting |
| 31/03/2022 | FY 2021 Earnings Release |
| 30/11/2021 | Q3 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 |
|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,00 | 5,18 3,20 61.97% | 0,00 |
|
EBITDA Million SEK | Released Forecast Spread | 0,00 | -40,0 -40,5 1.27% | 0,00 |
|
EBIT Million SEK | Released Forecast Spread | 0,00 | -40,0 -40,5 1.27% | 0,00 |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
Net income Million SEK | Released Forecast Spread | -34,3 | 0,00 0,00 - | -27,0 |
|
EPS SEK | Released Forecast Spread | -1,42 | 0,00 0,00 - | -0,53 |
| Announcement Date | 31/03/22 | 31/03/23 | 29/02/24 |
Quarterly results
| Fiscal Period | December | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2024 Q1 | 2024 Q2 |
|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 1,96 0,00 - | 5,32 0,00 - | 2,46 0,00 - | 0,00 | 0,00 |
|
EBITDA Million SEK | Released Forecast Spread | -12,5 -15,8 20.94% | -5,03 -21,6 76.72% | -8,04 -21,6 62.79% | -6,90 | -6,90 |
|
EBIT Million SEK | Released Forecast Spread | -12,5 -15,8 20.94% | -5,03 -21,6 76.72% | -8,04 -21,6 62.79% | -6,90 | -6,90 |
| Announcement Date | 31/03/23 | 31/05/23 | 14/08/23 | - | - |
| Today 03:30 pm | AURINIA PHARMACEUTICALS INC.: Q1 2024 Earnings Release |
| Today 04:00 pm | SPRINGWORKS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| Today 04:00 pm | REGENERON PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| Today 04:30 pm | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| Today 08:30 pm | GENMAB A/S: Q1 2024 Earnings Release |
| Today 01:31 am | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 06/05/2024 | FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | MERUS N.V.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | VAXCYTE, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Biosergen AB
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BIOSGN Stock
- Calendar Biosergen AB
